<SEC-DOCUMENT>0001964306-26-000033-index.html : 20260112
<SEC-HEADER>0001964306-26-000033.hdr.sgml : 20260112
<ACCEPTANCE-DATETIME>20260112160244
ACCESSION NUMBER:		0001964306-26-000033
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260112
DATE AS OF CHANGE:		20260112

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acumen Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001576885
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				364108129
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40551
		FILM NUMBER:		26526695

	BUSINESS ADDRESS:	
		STREET 1:		1210-1220 WASHINGTON STREET
		STREET 2:		SUITE 210
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02465
		BUSINESS PHONE:		617-344-4190

	MAIL ADDRESS:	
		STREET 1:		1210-1220 WASHINGTON STREET
		STREET 2:		SUITE 210
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02465

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OConnell Daniel Joseph
		CENTRAL INDEX KEY:			0001865136
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O ACUMEN PHARMACEUTICALS, INC.
		STREET 2:		427 PARK STREET
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22902
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>